CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies into creating novel cell-based immunotherapies for the treatment of human cancers. The development of its novel technologies has been inspired by the clinical success of existing C... CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies into creating novel cell-based immunotherapies for the treatment of human cancers. The development of its novel technologies has been inspired by the clinical success of existing CAR-T cells in treating hematological malignancies as well as the current clinical limitations and commercial challenges in extrapolating the CAR-T principle into the treatment of solid tumors. Show more
SINGAPORE, March 18, 2024 (GLOBE NEWSWIRE) -- CytoMed Therapeutics Limited (NASDAQ: GDTC) (“CytoMed” or “Company”), a Singapore-based biopharmaceutical company focused on harnessing its...
SINGAPORE, March 04, 2024 (GLOBE NEWSWIRE) -- CytoMed Therapeutics Limited (NASDAQ: GDTC) (“CytoMed” or “Company”), a Singapore-based biopharmaceutical company focused on harnessing its...
SINGAPORE, Jan. 29, 2024 (GLOBE NEWSWIRE) -- CytoMed Therapeutics Limited (NASDAQ: GDTC) (“CytoMed” or “Company”), a Singapore-based biopharmaceutical company focused on harnessing its...
CytoMed Therapeutics Signs HOA and MOU to Advance Research on Allogeneic Gamma Delta T Cell Technology PR Newswire SINGAPORE, Dec. 5, 2023 SINGAPORE, Dec. 5, 2023 /PRNewswire/ -- CytoMed...
CytoMed Therapeutics Reports First Half 2023 Financial Report and Provides Corporate Update PR Newswire SINGAPORE, Nov. 17, 2023 Conference call webcast is scheduled for November 22 at 9 a.m...
CytoMed Therapeutics to Present at The Benchmark Company's Upcoming Discovery One-on-One Investor Conference PR Newswire SINGAPORE, Nov. 14, 2023 SINGAPORE, Nov. 14, 2023 /PRNewswire/ -- CytoMed...
Chinese Patent Granted for CytoMed Therapeutics' Licensed iPSC-Based Technology PR Newswire SINGAPORE, Sept. 25, 2023 SINGAPORE, Sept. 25, 2023 /PRNewswire/ -- CytoMed Therapeutics Limited...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.09 | -4.34782608696 | 2.07 | 2.08 | 1.89 | 2974 | 1.93984478 | CS |
4 | -0.11 | -5.26315789474 | 2.09 | 2.169 | 1.89 | 2962 | 2.02558199 | CS |
12 | -0.2 | -9.17431192661 | 2.18 | 2.48 | 1.89 | 4669 | 2.08981756 | CS |
26 | -2.34 | -54.1666666667 | 4.32 | 5.5 | 1.89 | 30154 | 3.7465534 | CS |
52 | -0.89 | -31.0104529617 | 2.87 | 9.25 | 1.89 | 125839 | 5.06030267 | CS |
156 | -2.02 | -50.5 | 4 | 9.25 | 1.89 | 130659 | 4.78556432 | CS |
260 | -2.02 | -50.5 | 4 | 9.25 | 1.89 | 130659 | 4.78556432 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.